Characteristics and Survival of Patients With Advanced Cancer and P53 Mutations

Oncotarget - United States
doi 10.18632/oncotarget.2004
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Nondisruptive P53 Mutations Are Associated With Shorter Survival in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Nivolumab Improves Survival for Patients With Advanced Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Tumor Protein P53 and K-Ras Gene Mutations in Peruvian Patients With Gallbladder Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Improved Survival in Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Goserelin

New England Journal of Medicine
Medicine
1997English

RB1CC1 Together With RB1 and P53 Predicts Long-Term Survival in Japanese Breast Cancer Patients

PLoS ONE
Multidisciplinary
2010English

Pretreatment Direct Bilirubin and Total Cholesterol Are Significant Predictors of Overall Survival in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutations

International Journal of Cancer
Cancer ResearchOncology
2017English

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

JAMA Surgery
Surgery
2018English

Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy

Clinical Genitourinary Cancer
OncologyUrology
2018English

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy